1. Home
  2. SQFT vs ENSC Comparison

SQFT vs ENSC Comparison

Compare SQFT & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Presidio Property Trust Inc.

SQFT

Presidio Property Trust Inc.

HOLD

Current Price

$3.94

Market Cap

5.4M

Sector

Real Estate

ML Signal

HOLD

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$1.66

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQFT
ENSC
Founded
1999
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
6.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
SQFT
ENSC
Price
$3.94
$1.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.3K
82.9K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,525,365.00
$4,487,973.00
Revenue This Year
$23.63
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.51
52 Week Low
$3.75
$1.46
52 Week High
$23.00
$10.96

Technical Indicators

Market Signals
Indicator
SQFT
ENSC
Relative Strength Index (RSI) 39.47 35.68
Support Level $3.75 $1.46
Resistance Level $4.40 $1.85
Average True Range (ATR) 0.30 0.15
MACD 0.00 -0.01
Stochastic Oscillator 40.37 25.71

Price Performance

Historical Comparison
SQFT
ENSC

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: